Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.

Houlihan WJ, Ahmad UF, Koletar J, Kelly L, Brand L, Kopajtic TA.

J Med Chem. 2002 Sep 12;45(19):4110-8.

PMID:
12213054
2.

Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.

Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA.

J Med Chem. 2002 Sep 12;45(19):4097-109.

PMID:
12213053
4.

Novel tropane-based irreversible ligands for the dopamine transporter.

Zou MF, Kopajtic T, Katz JL, Wirtz S, Justice JB Jr, Newman AH.

J Med Chem. 2001 Dec 6;44(25):4453-61.

PMID:
11728190
6.

Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.

Houlihan WJ, Boja JW, Parrino VA, Kopajtic TA, Kuhar MJ.

J Med Chem. 1996 Dec 6;39(25):4935-41.

PMID:
8960553
7.

2'-substituted analogs of cocaine: synthesis and dopamine transporter binding potencies.

el-Moselhy TF, Avor KS, Basmadjian GP.

Arch Pharm (Weinheim). 2001 Sep;334(8-9):275-8.

PMID:
11688137
8.

Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives.

Lomenzo SA, Izenwasser S, Katz JL, Terry PD, Zhu N, Klein CL, Trudell ML.

J Med Chem. 1997 Dec 19;40(26):4406-14.

PMID:
9435910
9.
12.

Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects.

Katz JL, Izenwasser S, Terry P.

Psychopharmacology (Berl). 2000 Jan;148(1):90-8.

PMID:
10663422
13.

Cocaine induction of dopamine transporter trafficking to the plasma membrane.

Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L.

Mol Pharmacol. 2002 Feb;61(2):436-45.

14.

Synthesis and biological evaluation of meperidine analogues at monoamine transporters.

Lomenzo SA, Rhoden JB, Izenwasser S, Wade D, Kopajtic T, Katz JL, Trudell ML.

J Med Chem. 2005 Mar 10;48(5):1336-43.

PMID:
15743177
15.

High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.

Ghorai SK, Cook C, Davis M, Venkataraman SK, George C, Beardsley PM, Reith ME, Dutta AK.

J Med Chem. 2003 Mar 27;46(7):1220-8.

PMID:
12646032
16.

Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.

Tamiz AP, Zhang J, Flippen-Anderson JL, Zhang M, Johnson KM, Deschaux O, Tella S, Kozikowski AP.

J Med Chem. 2000 Mar 23;43(6):1215-22.

PMID:
10737754
17.

Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.

Kozikowski AP, Araldi GL, Boja J, Meil WM, Johnson KM, Flippen-Anderson JL, George C, Saiah E.

J Med Chem. 1998 May 21;41(11):1962-9.

PMID:
9599245
18.

Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.

Husbands SM, Izenwasser S, Kopajtic T, Bowen WD, Vilner BJ, Katz JL, Newman AH.

J Med Chem. 1999 Oct 21;42(21):4446-55.

PMID:
10543888

Supplemental Content

Support Center